arrow
R

Roberto Salvioni

urology
H指数:45
被引数:8,200

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Active surveillance for renal masses up to 2 cm: long-term oncological outcomes from a prospective multi-institutional study

对于2厘米及以下肾肿块的主动监测:一项前瞻性多中心研究的长期肿瘤学结局

2026-04-280
PRE
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study

验证用于透明细胞肾细胞癌的新型三维 (3D融合) 总体采样方案以克服肿瘤内异质性: Meet-Uro 18研究

2022-04-305
OAAI
Patterns of Recurrence Following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies
2021-10-0115
OA
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma
2021-10-0129
OAAI
A risk calculator predicting recurrence in lymph node metastatic penile cancer
2020-08-0712
OAAI
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: A multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica (vol 137, pg 154, 2019)
2020-02-012
OAAI
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica

男性睾丸生殖细胞肿瘤的监测和随访建议: 意大利生殖细胞癌症小组和意大利肿瘤学协会的多学科共识会议

2019-05-017
PREAI
Preoperative pembrolizumab (pembro) before radical cystectomy (RC) for muscle-invasive urothelial bladder carcinoma (MIUC): Interim clinical and biomarker findings from the phase II PURE-01 study
2018-07-012
PRE
Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center
2018-03-0120
PREAI
First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study

口服pan-her酪氨酸激酶抑制剂达克替尼一线治疗局部晚期或转移性阴茎鳞状细胞癌: 一项开放标签,单臂,单中心,2期研究的结果

2017-10-0469
OAAI
NEOADJUVANT SORAFENIB, GEMCITABINE, AND CISPLATIN (SGC) FOR MUSCLE-INVASIVE UROTHELIAL BLADDER CANCER (MIUBC): FINAL RESULTS AND TRANSLATIONAL FINDINGS OF AN OPEN-LABEL, SINGLE-ARM, PHASE 2 STUDY.
2017-04-010
PREAI